series-c-plus
Stage
About
Fate Therapeutics is a clinical-stage biopharmaceutical company developing induced pluripotent stem cell (iPSC)-derived, off-the-shelf cellular immunotherapies — including engineered NK and T cell products — for cancer and immune disorders.
Explore Fate Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.